Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|May 2, 2002
Synthesis and anti-tubercular evaluation of 4-quinolylhydrazonesLuisa Savini, Luisa Chiasserini, Alessandra Gaeta, et al.Journal of Inorganic Biochemistry|May 5, 2005
Structural study of ribonucleotide reductase inhibitor hydrazones. Synthesis and X-ray diffraction analysis of a copper(II)-benzoylpyridine-2-quinolinyl hydrazone complexGabriella Tamasi, Luisa Chiasserini, Luisa Savini, et al.Recent Patents on Anti-Infective Drug Discovery|August 27, 2010
Malaria chemotherapy: recent advances in drug developmentSandra Gemma, Valter Travagli, Luisa Savini, et al.European Journal of Medicinal Chemistry|February 28, 2004
New alpha-(N)-heterocyclichydrazones: evaluation of anticancer, anti-HIV and antimicrobial activityLuisa Savini, Luisa Chiasserini, Valter Travagli, et al.Journal of Medicinal Chemistry|December 28, 2002
Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitorsLuisa Savini, Alessandra Gaeta, Caterina Fattorusso, et al.Bioorganic & Medicinal Chemistry Letters|June 10, 2014
Rational design of the first difluorostatone-based PfSUB1 inhibitorsSimone Giovani, Maria Penzo, Simone Brogi, et al.Bioorganic & Medicinal Chemistry|November 8, 2003
High affinity central benzodiazepine receptor ligands. Part 3: insights into the pharmacophore and pattern recognition study of intrinsic activities of pyrazolo[4,3-c]quinolin-3-onesAndrea Carotti, Cosimo Altomare, Luisa Savini, et al.Bioorganic & Medicinal Chemistry Letters|October 1, 2010
Discovery of potent nucleotide-mimicking competitive inhibitors of hepatitis C virus NS3 helicaseSandra Gemma, Stefania Butini, Giuseppe Campiani, et al.Bioorganic & Medicinal Chemistry Letters|July 17, 2012
Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1Sandra Gemma, Simone Giovani, Margherita Brindisi, et al.Bioorganic & Medicinal Chemistry|July 22, 2009
Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studiesSandra Gemma, Luisa Savini, Maria Altarelli, et al.Pageof 2